Journal of Lower Genital Tract Disease publishes a clinical trial endorsing PAPILOCARE as a proven treatment that prevents and treats lesions caused by HPV
of patients affected by high-risk HPV
The Paloma Clinical trial also certifies a clearance of HPV in 63% of patients with high-risk HPV treated with PAPILOCARE compared with 40% in the control group.
MADRID, Spain, April 7, 2021 /PRNewswire/
The
Journal of Lower Genital Tract Disease (JLGTD), the official journal of the American Society for Colposcopy and Cervical Pathology (ASCCP),
have published the final results of the Paloma Clinical Trial, which demonstrated the efficacy of PAPILOCARE in preventing and treating lesions caused by HPV. Its main conclusions include the